Mycophenolate mofetil

In immunology, mycophenolate mofetil (brand name Cellcept)is an immunosuppressive agent.

History
Cellcept brand of mycophenolate mofetil was approved for Roche Palo by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 1995. A generic version with a AB Therapeutic Equivalence Code was approved for Sandoz with a Abbreviated New Drug Application (ANDA) in 2008.